Lilly Oncology To Unveil More Than 50 Studies At Asco 2008

Main Category: Cancer / Oncology
Article Date: 07 May 2008 - 4:00 PDT

Current ratings for:
'Lilly Oncology To Unveil More Than 50 Studies At Asco 2008'

Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (1 votes)


Eli Lilly and Company will unveil data from more than 50 studies at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from May 30 to June 3, 2008. The company will present the latest research findings on ALIMTA® (pemetrexed for injection), GEMZAR® (gemcitabine HCl for injection), and enzastaurin, an investigational, oral, targeted therapy. The majority of the studies being presented are findings that support Lilly's leadership in thoracic cancer research.

Of note is a pivotal Phase III study (ASCO Abstract # 8060) that demonstrated a key correlation between lung cancer histology (tissue type), treatment choice and patient outcome. It will be one of the studies featured on Thursday, May 15 in ASCO's live online presscast. The virtual press event will be the first time ASCO has selected researchers to present key abstracts prior to its annual meeting.

"Improved patient outcomes via tailored therapy continues to be our focus and this year's ASCO is no exception," said Richard Gaynor, M.D., Lilly vice president, cancer research and global oncology platform leader. "With Lilly studies focusing on thoracic and breast cancer, among others, this meeting will continue to show our commitment to answering the unmet needs of cancer care."

Key Pemetrexed Abstracts for ASCO 2008:

-- Abstract # 8060: June 2, 2008; 3:00 p.m.
- Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study
- This study will be featured during ASCO presscast on May 15

-- Abstract # 8096: June 1, 2008; 2:00 p.m.
- Comparison of patient outcomes stratified by histology among pemetrexed-treated patients with stage IIIB/IV NSCLC in two Phase II trials

-- Abstract # 8097: June 1, 2008; 2:00 p.m.
- Resource utilization by non-small cell lung cancer histology: Results from the randomized, phase III trial of pemetrexed/cisplatin versus gemcitabine/cisplatin


Lilly Oncology

View drug information on Alimta; Gemzar.


Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Lilly Oncology. "Lilly Oncology To Unveil More Than 50 Studies At Asco 2008." Medical News Today. MediLexicon, Intl., 7 May. 2008. Web.
22 May. 2012. <http://www.medicalnewstoday.com/releases/106599.php>

APA
Lilly Oncology. (2008, May 7). "Lilly Oncology To Unveil More Than 50 Studies At Asco 2008." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/106599.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Lilly Oncology To Unveil More Than 50 Studies At Asco 2008'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »